Valproic Acid
Valproic Acid is an orally bioavailable HDAC inhibitor that suppresses HDAC1 and degrades HDAC2. It activates Notch1 signaling, inhibiting small cell lung carcinoma cell proliferation in vitro, and is widely used in neurological research models for epilepsy and bipolar disorder.
Product Specifications
CAS Number
99-66-1
Product Name Alternative
Inhibitor, Histone deacetylases, HIV, HIV Protease, HIVProtease, HDAC1, HDAC, HDACs, headaches, hepatic fat accumulation, Endogenous Metabolite, epilepsy, GABA, GABA Receptor, GABAReceptor, Gammasecretase, Human immunodeficiency virus, Notch1, Notch, inhibit, Mitophagy, migraine, Mitochondrial Autophagy, anticonvulsant, anticancer, Apoptosis, Autophagy, bipolar disorder, 2-Propylpentanoic Acid, 2-Propylvaleric Acid, Depakine, degradation, proteasomal, Sodium valproate, SodiumChannel, small cell lung cancer, Sodium Channel, SCLC, Valproic Acid, VPA
Field of Research
Cell Biology, Epigenetics & Chromatin, Infectious Disease & Virology, Metabolism Research, Molecular Biology, Neuroscience, Pharmacology & Drug Discovery, Protein Biochemistry, Stem Cell & Developmental Biology
Purity
97.78% (May vary between batches)
Solubility
DMSO:100 mg/mL (693.43 mM) ; H2O:1 mg/mL (6.93 mM) ;5% DMSO+95% Saline:5 mg/mL (34.67 mM)
Smiles
CCCC (CCC) C (O) =O
Molecular Formula
C8H16O2
Molecular Weight
144.21
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6273241-01 0.1 mL
AMICA1, NT (AMICA1, JAML, Junctional adhesion molecule-like, Adhesion molecule interacting with CXADR antigen 1, Dendritic cell-specific protein CREA7-1) (MaxLight 490)
Sign In for Pricing
View Details